← Back to Search

Other

QL Block vs PENG + LFC Block for Postoperative Pain After Hip Replacement

N/A

Waitlist Available

Led By Ellen Hay, MD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age greater than or equal to 18 years of age

Undergoing elective hip arthroplasty with planned same day discharge

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-72 hours postoperatively

Awards & highlights

Study Summary

This trial will compare pain relief & opioid use in patients who have elective hip surgery, with the goal of improving post-op pain control.

Who is the study for?

This trial is for adults over 18 who are having elective hip replacement surgery and plan to go home the same day. They must be able to consent to the study. People with local anesthetic allergies, weighing under 40kg, or with known substance abuse issues cannot join.Check my eligibility

What is being tested?

The study compares two types of nerve blocks for pain relief after hip surgery: QL Block versus PENG + LFC Block. Patients will be randomly assigned one of these before their operation to see which better reduces opioid use and pain in the first three days post-surgery.See study design

What are the potential side effects?

Potential side effects may include typical reactions related to nerve blocks such as discomfort at injection site, numbness beyond targeted areas, weakness in legs, or less commonly, infection or bleeding where the block was performed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for hip surgery with plans to go home the same day.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-72 hours postoperatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-72 hours postoperatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-72 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Postoperative cumulative opioid consumption

Secondary outcome measures

Postoperative pain score measures

Other outcome measures

Number of opioid related side-effects

Overall hip health

PACU Duration

+3 more

Trial Design

2Treatment groups

Active Control

Group I: PENG + LFC BlockActive Control1 Intervention

The pericapsular nerve group (PENG) block is an ultrasound-guided approach, first described by Giron-Arango et al. for the blockade of the articular branches of the femoral, obturator and accessory obturator nerves that provide sensory innervation to the anterior hip capsule [5,6]. In the PENG block, a low-frequency, curvilinear probe is used to visualize the anterior inferior iliac spine, iliopsoas tendon, and iliopubic eminence. After placing a subcutaneous skin wheel with lidocaine, a blunt regional anesthesia needle is inserted using in-plane ultrasound guidance. The needle is advanced until the tip lies on the lateral and inferior margin of the iliopsoas tendon between the anterior inferior iliac spine (lateral) and iliopubic eminence (deep).

Group II: QL BlockActive Control1 Intervention

The lateral QL block is performed by injecting local anesthetic deep to the transversus abdominis aponeurosis and superficial to the fascia transversalis with direct ultrasound guidance. After completing consent, placing monitors and providing mild sedation, the patient is positioned laterally and the muscular anatomy (external oblique, internal oblique, transverse abdominis, quadratus lumborum and latissimus dorsi muscles) identified. After placing a subcutaneous skin wheel with lidocaine, a blunt regional anesthesia needle is inserted using in-plane ultrasound guidance. Local anesthetic is deposited incrementally with frequent aspiration in the anterolateral border of the quadratus lumborum muscle at the junction of the transversalis fascia, outside the anterior layer of the thoracolumbar fascia and superficial to the fascia transversalis.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,284 Total Patients Enrolled

1 Trials studying Postoperative Pain

62 Patients Enrolled for Postoperative Pain

Ellen Hay, MDPrincipal InvestigatorMedical University of South Carolina

Media Library

PENG + LFC Block (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05710107 — N/A

Postoperative Pain Research Study Groups: PENG + LFC Block, QL Block

Postoperative Pain Clinical Trial 2023: PENG + LFC Block Highlights & Side Effects. Trial Name: NCT05710107 — N/A

PENG + LFC Block (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05710107 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants still being sought for this experiment?

"Affirmative. According to the information accessible on clinicaltrials.gov, this research is actively recruiting participants who initially signed up for the trial in February of 2023 and was last updated at March 1st, 2023. A total of 106 volunteers from a single location are being sought after by the study's organisers."

Answered by AI

What is the scope of participants for this research program?

"Affirmative. According to clinicaltrials.gov, this experiement began on February 7th 2023 and was recently revised on March 1st 2023; thus, it is currently in search of 106 participants from one medical location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

QL vs PENG for Analgesia After Hip Arthroplasty

Ellen Hay 2023. "QL vs PENG for Analgesia After Hip Arthroplasty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05710107.